Inhaled corticosteroids have an essential role in the management of many patients with asthma,1 improving control and reducing the need for oral corticosteroids. Used in conventional dosage inhaled corticosteroids are very safe; in high dosage systemic effects are more evident. Fluticasone propionate (Flixotide - Allen & Hanburys), a new inhalation corticosteroid, is promoted as being more potent than conventional preparations (beclomethasone dipropionate and budesonide) and less likely to cause systemic effects. Is this claim justified and what is the place of fluticasone propionate in asthma prophylaxis?
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.